Diabetes > Trials > Peripheral Neuropathy Studies

Studies for Diabetics Diagnosed with Peripheral Neuropathy

The studies test a new method to manage the pain caused by this condition. Studies are open to both men and women.

ICON typically pays volunteers between £400 - £3500 for their participation on studies dependent on the length of time it takes to complete.

To take part, you must:

  • Have Type 1 or Type 2 diabetes
  • Be aged 18-75 years old
  • Have confirmed Peripheral Neuropathy (a condition causing pain and burning in the lower leg and feet)
  • Been diagnosed by your doctor with the condition for at least 6 months and no longer than 5 years.
  • Be willing to stop using your neuropathy medications for the duration of the studies so we can monitor the impact of the new method
  • Not be suffering from depression, epilepsy, or any condition affecting your blood, stomach, lungs, heart, kidneys or skin
  • If female: be surgically sterile or post menopausal

The studies are running now and we are looking for people to start ASAP.  We will work with you to identify study dates to suit you.

If you believe you may be suitable for these studies and would like to register your interest, please complete the application questions as honestly and accurately as possible. 

You’ll then receive a telephone call from a member of our team within a few days and they will arrange for you to visit our Manchester-based research centre to speak with one of our doctors about trials. 

We would then perform a health check to identify your suitability to take part. We will pay you up to £35 for travel expenses to your screening appointment (dependent on your location).

Who is running these studies? ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis. We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution.